CCND1 and prostate carcinoma: Indeed, the AR-mediated mechanisms responsible for cyclin D1 and D2 down-regulation by androgen in HPr-1AR differ from the post-transcriptional mechanism that reportedly increases cyclin D1/2 expression in LNCaP prostate cancer cells [91].